MONROVIA, CA, November 07, 2008
/24-7PressRelease/ -- This event is one of the leading CNS disease partnering forums bringing together members of government, industry and academia to discuss the latest advancements in the field. Leaders in business development and CNS diseases will present on new advancements in CNS disease research and development including recent deals and collaborations, R&D models and new technologies.
This very specialized summit takes a microscopic look at trends and developments in CNS diseases, from cutting-edge CNS disease research to early and late stage partnerships. This conference helps its delegates grasp a full scope of the market for new treatments and therapies for all types of CNS diseases.
A Joint featured presentation will be given by Michael Shih, Director of Business Development at Eisai Inc. and Deepa Talpade, Director of Global Licensing & Strategic Alliances at Schering Plough. The presentation is entitled: CNS Deal Outlook: What We Can Learn from Recent Trends.
For more information on attending, presenting a poster, or sponsoring, please visit http://gtcbio.com/conferenceDetails.aspx?id=140.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
# # #
Read more Press Releases from Rania Hafez:- De Yang from the National Cancer Institute to Speak at the 7th Cytokines & Inflammation Conference
- Gregory A. Bonfiglio, Managing Partner at Proteus Venture Partners to Give Featured Presentation at 5th Stem Cell Research & Therapeutics Conference
- Charles Peterfy, Chief Scientific Officer at Synarc to Give Featured Presentation at GTCbio's 4th Imaging in Preclinical & Clinical Drug Development Conference
- Michael Karin, Professor at UCSD to Give Keynote Speech at 7th Cytokines & Inflammation Conference
- GTCbio Announces its 7th Annual Cytokines & Inflammation Conference
- Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center to Give Keynote Speech at GTCbio's 2nd Oncology Biomarkers Conference on January 19-20 in Miami, Florida
- GTCbio Announces its 2nd Annual Oncology Biomarkers Conference
- Michael Shih, Director of Business Development at Eisai Inc. and Deepa Talpade, Director of Global Licensing & Strategic Alliances at Schering Plough to Give Joint Featured Presentation at GTCbio's CNS Diseases Partnering & Deal-Making Summit on Dec. 1-2, 2008 in Boston, MA
- Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 - San Diego, CA)
- Herbert Fritsche, Professor and Chief of Clinical Chemistry at MD Anderson Cancer Center to Give Keynote Presentation at GTCbio's Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
Other Press Release Headlines:
